US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 5.0700
  • -0.4200-7.65%
Close Dec 20 16:00 ET
  • 5.0700
  • 0.00000.00%
Post 20:01 ET
7.53MMarket Cap-0.50P/E (TTM)

Evoke Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
69.83%2.65M
125.51%2.55M
114.15%1.74M
106.51%5.18M
110.45%1.68M
87.82%1.56M
144.99%1.13M
93.70%810.41K
55.04%2.51M
120.86%796.37K
Operating revenue
69.83%2.65M
125.51%2.55M
114.15%1.74M
106.51%5.18M
110.45%1.68M
87.82%1.56M
144.99%1.13M
93.70%810.41K
55.04%2.51M
120.86%796.37K
Cost of revenue
197.99%104.02K
-27.68%41.48K
82.90%92.53K
-45.50%201.88K
-68.95%59.02K
-61.12%34.91K
-15.37%57.36K
122.28%50.59K
12.88%370.39K
39.07%190.08K
Gross profit
66.90%2.55M
133.69%2.51M
116.23%1.64M
132.84%4.98M
166.70%1.62M
105.83%1.53M
172.58%1.07M
92.06%759.82K
65.76%2.14M
170.79%606.29K
Operating expense
22.50%3.84M
30.61%3.73M
7.86%3.14M
25.04%12.41M
51.33%3.5M
17.95%3.13M
14.03%2.86M
19.13%2.91M
5.11%9.92M
30.76%2.32M
Selling and administrative expenses
22.12%3.82M
34.97%3.73M
10.24%3.14M
27.06%12.23M
52.14%3.48M
19.77%3.13M
19.48%2.77M
18.41%2.85M
8.73%9.62M
31.88%2.29M
Research and development costs
--11.68K
--0
-93.07%4.65K
-39.52%181.91K
-17.08%22.56K
--0
-51.77%92.36K
60.58%66.99K
-49.06%300.79K
-23.84%27.21K
Operating profit
19.82%-1.29M
31.43%-1.22M
30.34%-1.5M
4.56%-7.43M
-10.42%-1.89M
16.16%-1.6M
15.54%-1.78M
-5.07%-2.16M
4.48%-7.79M
-10.50%-1.71M
Net non-operating interest income expense
70.45%-26.73K
47.71%-43.66K
10.64%-78.6K
17.49%-361.4K
-6.47%-99.48K
10.70%-90.47K
30.85%-83.49K
28.19%-87.96K
10.87%-437.99K
25.25%-93.44K
Non-operating interest income
179.25%99.29K
96.78%81K
30.36%46.06K
123.52%138.6K
-18.55%26.54K
43.88%35.56K
952.79%41.16K
4,344.15%35.33K
619.76%62.01K
3,098.04%32.59K
Non-operating interest expense
-0.00%126.03K
-0.00%124.66K
1.11%124.66K
0.00%500K
0.00%126.03K
0.00%126.03K
0.00%124.66K
0.00%123.29K
-0.01%500K
0.00%126.03K
Other net income (expense)
Income before tax
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
Income tax
Net income
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
Net income continuous Operations
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
Minority interest income
Net income attributable to the parent company
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
3.68%-8.22M
-7.82%-1.8M
Basic earnings per share
84.54%-0.94
86.14%-0.93
74.63%-2.04
11.07%-27.96
-11.95%-7.12
15.56%-6.08
21.24%-6.71
16.25%-8.04
17.61%-31.44
13.11%-6.36
Diluted earnings per share
84.54%-0.94
86.14%-0.93
74.63%-2.04
11.07%-27.96
-11.95%-7.12
15.56%-6.08
21.24%-6.71
16.25%-8.04
17.61%-31.44
13.11%-6.36
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 69.83%2.65M125.51%2.55M114.15%1.74M106.51%5.18M110.45%1.68M87.82%1.56M144.99%1.13M93.70%810.41K55.04%2.51M120.86%796.37K
Operating revenue 69.83%2.65M125.51%2.55M114.15%1.74M106.51%5.18M110.45%1.68M87.82%1.56M144.99%1.13M93.70%810.41K55.04%2.51M120.86%796.37K
Cost of revenue 197.99%104.02K-27.68%41.48K82.90%92.53K-45.50%201.88K-68.95%59.02K-61.12%34.91K-15.37%57.36K122.28%50.59K12.88%370.39K39.07%190.08K
Gross profit 66.90%2.55M133.69%2.51M116.23%1.64M132.84%4.98M166.70%1.62M105.83%1.53M172.58%1.07M92.06%759.82K65.76%2.14M170.79%606.29K
Operating expense 22.50%3.84M30.61%3.73M7.86%3.14M25.04%12.41M51.33%3.5M17.95%3.13M14.03%2.86M19.13%2.91M5.11%9.92M30.76%2.32M
Selling and administrative expenses 22.12%3.82M34.97%3.73M10.24%3.14M27.06%12.23M52.14%3.48M19.77%3.13M19.48%2.77M18.41%2.85M8.73%9.62M31.88%2.29M
Research and development costs --11.68K--0-93.07%4.65K-39.52%181.91K-17.08%22.56K--0-51.77%92.36K60.58%66.99K-49.06%300.79K-23.84%27.21K
Operating profit 19.82%-1.29M31.43%-1.22M30.34%-1.5M4.56%-7.43M-10.42%-1.89M16.16%-1.6M15.54%-1.78M-5.07%-2.16M4.48%-7.79M-10.50%-1.71M
Net non-operating interest income expense 70.45%-26.73K47.71%-43.66K10.64%-78.6K17.49%-361.4K-6.47%-99.48K10.70%-90.47K30.85%-83.49K28.19%-87.96K10.87%-437.99K25.25%-93.44K
Non-operating interest income 179.25%99.29K96.78%81K30.36%46.06K123.52%138.6K-18.55%26.54K43.88%35.56K952.79%41.16K4,344.15%35.33K619.76%62.01K3,098.04%32.59K
Non-operating interest expense -0.00%126.03K-0.00%124.66K1.11%124.66K0.00%500K0.00%126.03K0.00%126.03K0.00%124.66K0.00%123.29K-0.01%500K0.00%126.03K
Other net income (expense)
Income before tax 22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M
Income tax
Net income 22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M
Net income continuous Operations 22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M
Minority interest income
Net income attributable to the parent company 22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M3.68%-8.22M-7.82%-1.8M
Basic earnings per share 84.54%-0.9486.14%-0.9374.63%-2.0411.07%-27.96-11.95%-7.1215.56%-6.0821.24%-6.7116.25%-8.0417.61%-31.4413.11%-6.36
Diluted earnings per share 84.54%-0.9486.14%-0.9374.63%-2.0411.07%-27.96-11.95%-7.1215.56%-6.0821.24%-6.7116.25%-8.0417.61%-31.4413.11%-6.36
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List